- Home
- RSLS vs AZTR Comparison
RSLS vs AZTR Comparison
Compare RSLS & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- AZTR
- Stock Information
- Founded
- RSLS 2002
- AZTR 2014
- Country
- RSLS United States
- AZTR United States
- Employees
- RSLS N/A
- AZTR N/A
- Industry
- RSLS Medical/Dental Instruments
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- RSLS Health Care
- AZTR Health Care
- Exchange
- RSLS Nasdaq
- AZTR Nasdaq
- Market Cap
- RSLS 3.2M
- AZTR 3.2M
- IPO Year
- RSLS 2007
- AZTR 2023
- Fundamental
- Price
- RSLS $3.57
- AZTR $0.31
- Analyst Decision
- RSLS Hold
- AZTR
- Analyst Count
- RSLS 1
- AZTR 0
- Target Price
- RSLS N/A
- AZTR N/A
- AVG Volume (30 Days)
- RSLS 43.6K
- AZTR 4.7M
- Earning Date
- RSLS 03-31-2025
- AZTR 03-14-2025
- Dividend Yield
- RSLS N/A
- AZTR N/A
- EPS Growth
- RSLS N/A
- AZTR N/A
- EPS
- RSLS N/A
- AZTR N/A
- Revenue
- RSLS $8,183,000.00
- AZTR $97,500.00
- Revenue This Year
- RSLS $17.47
- AZTR N/A
- Revenue Next Year
- RSLS $20.00
- AZTR N/A
- P/E Ratio
- RSLS N/A
- AZTR N/A
- Revenue Growth
- RSLS N/A
- AZTR N/A
- 52 Week Low
- RSLS $3.23
- AZTR $0.23
- 52 Week High
- RSLS $29.00
- AZTR $38.10
- Technical
- Relative Strength Index (RSI)
- RSLS 33.36
- AZTR 44.00
- Support Level
- RSLS $3.23
- AZTR $0.24
- Resistance Level
- RSLS $3.92
- AZTR $0.35
- Average True Range (ATR)
- RSLS 0.31
- AZTR 0.04
- MACD
- RSLS -0.08
- AZTR -0.00
- Stochastic Oscillator
- RSLS 19.21
- AZTR 13.58
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.